JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
Scope & Guideline
Bridging science and healthcare through cutting-edge research.
Introduction
Aims and Scopes
- Biomaterials Development:
Research on the design and synthesis of new biomaterials, including polymers, ceramics, and composites, tailored for specific medical applications. - Tissue Engineering:
Studies focused on creating biological substitutes that restore, maintain, or improve tissue function, utilizing scaffolds, hydrogels, and cell-based therapies. - Biocompatibility and Bioactivity:
Investigation into the interactions between biomaterials and biological systems, assessing their safety, effectiveness, and compatibility with human tissues. - Drug Delivery Systems:
Development of novel drug delivery platforms, including hydrogels and nanoparticles, for targeted and controlled release of therapeutic agents. - Regenerative Medicine:
Research aimed at understanding and utilizing biomaterials to promote tissue regeneration and healing, including strategies for stem cell therapies. - Nanotechnology in Biomaterials:
Exploration of nanomaterials and their applications in enhancing the properties and functionalities of biomaterials for biomedical use.
Trending and Emerging
- Smart Biomaterials:
Research on stimuli-responsive biomaterials that can change properties in response to environmental cues is on the rise, indicating a trend towards personalized and adaptive medical solutions. - 3D Printing and Bioprinting:
The use of additive manufacturing techniques for creating complex structures and scaffolds is increasingly popular, highlighting innovation in tissue engineering and regenerative medicine. - Sustainable and Bio-based Materials:
There is a growing interest in developing biomaterials from renewable resources, reflecting an emphasis on sustainability and environmental impact. - Cell-based Therapies:
Studies integrating biomaterials with stem cell technologies for regenerative applications are gaining momentum, underscoring the role of biomaterials in cell therapy. - Nanomedicine and Nanobiomaterials:
Research focusing on the application of nanotechnology in biomaterials, particularly for drug delivery and targeted therapy, is rapidly expanding. - Immunomodulatory Biomaterials:
The exploration of biomaterials that can modulate immune responses is becoming increasingly relevant, especially in the context of chronic inflammation and tissue regeneration.
Declining or Waning
- Traditional Biomaterials:
The focus on conventional biomaterials like simple polymers and metals is decreasing as newer, more complex materials and technologies gain prominence. - In vitro Models:
Research primarily using basic in vitro models for testing biomaterial interactions is becoming less common, with a shift towards more sophisticated in vivo and ex vivo models. - Static Testing Methods:
There is a waning interest in traditional static mechanical testing methods, with a growing demand for dynamic and physiologically relevant testing conditions. - Standardization of Biomaterials:
The emphasis on standardization protocols for biomaterials has diminished as researchers explore more innovative and application-specific approaches. - Long-term In Vivo Studies:
Longitudinal studies assessing the long-term performance of biomaterials in vivo are appearing less frequently, possibly due to the increasing complexity and cost of such studies.
Similar Journals
ACS Applied Materials & Interfaces
Transforming Research into Real-World ApplicationsACS Applied Materials & Interfaces, published by the American Chemical Society, stands as a leading journal in the field of applied materials, nanotechnology, and interdisciplinary research in medicine. With an impressive Impact Factor that places it in the Q1 category across Materials Science, Medicine, and Nanoscience and Nanotechnology, this journal consistently ranks among the top tier, evidencing its significance and influence in advancing scientific knowledge. The journal’s scopus ranking of 33 out of 463 in General Materials Science further underscores its critical role in disseminating innovative and high-quality research. Although it is not an open-access journal, a diverse range of access options is available, ensuring that vital research findings are accessible to a broad audience of researchers, professionals, and students. Targeting breakthroughs in the synthesis, characterization, and application of materials and interfaces, ACS Applied Materials & Interfaces serves as a pivotal platform for publishing cutting-edge studies essential for future technological advancements.
Materials Today Bio
Showcasing groundbreaking discoveries in bioengineering and biomaterials.Materials Today Bio, published by Elsevier, is an esteemed open-access journal dedicated to advancing the fields of bioengineering, biomaterials, and biomedical engineering. Since its inception in 2019, this journal has quickly made a name for itself, currently ranked Q1 in multiple categories including Bioengineering, Biomaterials, and Biotechnology, reflecting its exceptional quality and relevance in the rapidly evolving landscape of bio-related sciences. With an impressive Scopus ranking positioning it in the top 25% of its categories, Materials Today Bio provides a vital platform for researchers and professionals to share cutting-edge discoveries and innovative applications that bridge the gap between materials science and biological studies. Accessible to a global audience, this journal not only fosters collaboration among the scientific community but also aims to highlight significant advancements in cell and molecular biology, making it an indispensable resource for students and seasoned experts alike. The journal's commitment to open access since 2019 underscores its dedication to disseminating knowledge widely, ensuring that crucial findings reach those who can benefit from them the most.
Journal of Tissue Engineering and Regenerative Medicine
Empowering researchers with impactful insights in tissue engineering.Journal of Tissue Engineering and Regenerative Medicine, published by WILEY, stands as a pivotal platform in the fields of biomaterials, biomedical engineering, and regenerative medicine. With an ISSN of 1932-6254 and an E-ISSN of 1932-7005, this journal, based in the United Kingdom, has consistently delivered high-quality research since its inception in 2006, converging critical insights through 2024. With an impressive citation profile reflected in its Scopus rankings—specifically a rank of #58 in Medicine and #75 in Biomedical Engineering—the journal is acknowledged for its substantial impact, as demonstrated by its competitive quartile standings in 2023. Notably, it maintains a Q3 ranking in Biomaterials and Q2 in both Biomedical Engineering and Medicine (miscellaneous), showcasing its influence and relevance in the rapidly evolving interplay between engineering and medicine. The journal serves as a vital resource for researchers and practitioners aiming to stay abreast of innovations and breakthroughs in regenerative therapies, tissue scaffolds, and biomaterials. While not an open-access publication, it fosters academic dialogue and knowledge dissemination that is crucial for advancing the field.
Bioactive Materials
Empowering Researchers with Open Access to Transformative KnowledgeBioactive Materials, published by KEAI PUBLISHING LTD, stands as a leading Open Access journal in the fields of Biomaterials, Biomedical Engineering, and Biotechnology. Since its inception in 2016, this journal has rapidly ascended in prominence, currently holding a prestigious Q1 category ranking across multiple disciplines, reflecting its significant impact within the scientific community. With its E-ISSN 2452-199X, it spans a broad spectrum of research areas, contributing valuable insights to the ongoing discourse in bioactive materials and their applications. The journal's superior Scopus rankings further illustrate its influence, boasting impressive standings in engaging niches such as engineering and molecular biology. Bioactive Materials offers a vital platform for researchers, professionals, and students to disseminate and acquire cutting-edge knowledge, thus fostering innovation and collaboration in the rapidly evolving terrain of biomedicine. Its commitment to Open Access since 2016 enhances accessibility, ensuring that the burgeoning advancements in this field reach a global audience.
Materials
Pioneering discoveries in materials science for global impact.Materials is an esteemed journal published by MDPI, dedicated to advancing the fields of Condensed Matter Physics and Materials Science. With its commitment to Open Access since its inception in 2008, the journal has made significant strides in disseminating high-quality research globally, allowing researchers, professionals, and students easy access to cutting-edge studies without financial barriers. Hailing from Switzerland, the journal has shown remarkable growth and prominence, currently ranked in the Q2 quartile in its categories according to the latest assessments, which highlights its impact within the community. As the journal converges its focus from 2008 to 2024, it aims to continually foster a robust exchange of knowledge on innovative materials and their applications, thereby supporting the evolving landscape of science and technology. With an E-ISSN of 1996-1944 and a user-friendly platform, Materials is poised to be a leading choice for scholars eager to contribute to and engage with pioneering research.
Advanced NanoBiomed Research
Pioneering Research in NanobiomedicineAdvanced NanoBiomed Research is a pioneering open-access journal committed to advancing the interdisciplinary field of nanobiotechnology, published by WILEY-V C H VERLAG GMBH. Since its inception in 2021, this journal has provided a platform for innovative research that bridges the gap between engineering, medicine, and materials science. With impressive rankings in Scopus, positioning it within the top quartiles of various categories, Advanced NanoBiomed Research aims to disseminate high-quality research that contributes to the understanding and application of nanomaterials in biomedical contexts. As it encompasses a wide scope—from applied microbiology to biomaterials—it serves as an essential resource for researchers, professionals, and students eager to explore the cutting-edge developments in the field. The journal promotes a collaborative environment where emerging ideas can flourish, ensuring that vital advancements in nanobiomedicine can be shared and built upon within the scientific community.
Advanced Biomedical Engineering
Empowering knowledge sharing in engineering and biology.Advanced Biomedical Engineering is a peer-reviewed open access journal published by the Japanese Society for Medical & Biological Engineering, dedicated to disseminating high-quality research in the multidisciplinary fields of biomedical engineering. Boasting an ISSN of 2187-5219, this journal has been pivotal since its inception in 2018, especially as it embraces the open access model to foster knowledge sharing and wide accessibility. Centered in Tokyo, Japan, it serves as a vital platform for scholars and practitioners across various domains, such as biomaterials, biomedical engineering, and biotechnology. Despite currently residing in the Q4 quartile across several categories, including those in biotechnology and computer science applications, the journal is committed to elevating its academic impact and reputation, aiming for improved rankings in Scopus and other databases. Researchers and professionals are encouraged to contribute their innovative findings, discussions, and case studies, facilitating the advancement of this dynamic field.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
Driving Innovation in Biomaterials for Enhanced Patient CareJOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, published by Wiley, is a leading journal in the field of biomaterials and biomedical engineering, with an impact factor reflected in its relevant Scopus rankings—including a Q2 position in Biomedical Engineering and Q3 in Biomaterials for 2023. This journal, with ISSN 1552-4973 and E-ISSN 1552-4981, serves as a vital platform for disseminating pioneering research and innovative applications of biomaterials. Positioned in the United States, it aims to bridge the gap between material science and biological applications, fostering collaboration among researchers, professionals, and students dedicated to advancing technology in healthcare. With a convergence of studies from 2003 to 2024 and a growing focus on open access, the journal ensures greater visibility and accessibility for groundbreaking research. Join us in exploring the dynamic field of biomaterials, as we push the boundaries of science and engineering for improved patient outcomes.
Frontiers in Bioengineering and Biotechnology
Driving Breakthroughs in Biomedical Engineering and BeyondFrontiers in Bioengineering and Biotechnology, published by FRONTIERS MEDIA SA in Switzerland, stands as a leading platform for innovative research and developments in the fields of bioengineering and biotechnology. Since its inception in 2013, this Open Access journal has garnered significant recognition, reflected in its impressive category rankings: Q1 in Biomedical Engineering and Q2 in Bioengineering, Biotechnology, and Histology for 2023. With a focus on fostering collaboration and knowledge sharing, it aims to provide researchers, professionals, and students with access to pioneering studies that push the boundaries of science and technology. The journal, which is indexed in prominent databases, boasts high visibility and impact, evidenced by its impressive rankings across various categories in Scopus. As it continues to converge from 2013 to 2024, Frontiers in Bioengineering and Biotechnology is dedicated to shaping the discourse in its field and promoting advancements that have the potential to transform healthcare and environmental sustainability.
Materials Science & Engineering C-Materials for Biological Applications
Empowering discoveries in materials for biological innovation.Materials Science & Engineering C-Materials for Biological Applications is a premier journal published by ELSEVIER, dedicated to advancing the field of biomaterials through interdisciplinary research. With a robust ISSN of 0928-4931, this journal has made its mark in the realms of Chemical Engineering and Materials Science, achieving impressive Scopus rankings within its categories, namely Rank #16/151 in Bioengineering (89th percentile) and Rank #13/112 in Biomaterials (88th percentile). Although the journal's coverage in Scopus has been discontinued since 2021, it remains a critical resource for researchers, professionals, and students eager to explore innovative materials and their applications in biological contexts. The journal’s open access policy enhances its accessibility, fostering a global exchange of knowledge and inspiring future advancements in the field of materials science.